In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta
- Karolinska Institute, Sweden
- KTH Royal Institute of Technology, Sweden
Abstract
Here we present a method for in-depth human plasma proteome analysis based on high-resolution isoelectric focusing HiRIEF LC-MS/MS, demonstrating high proteome coverage, reproducibility and the potential for liquid biopsy protein profiling. By integrating genomic sequence information to the MS-based plasma proteome analysis we enable detection of single amino acid variants and for the first time demonstrate transfer of multiple protein variants between mother and fetus across the placenta. We further show that our method has the ability to detect both low abundance tissue-annotated proteins and phosphorylated proteins in plasma, as well as quantitate differences in plasma proteomes between the mother and the newborn as well as changes related to pregnancy.
Data availability
MS raw data are available via ProteomeXchange with identifier PXD010899.
-
Plasma HiRIEFProteomeXchange, PXD010899.
Article and author information
Author details
Funding
Vetenskapsrådet
- Maria Pernemalm
- AnnSofi Sandberg
- Yafeng Zhu
- Jorrit Boekel
- Claes-Göran Östenson
- Janne Lehtiö
Stiftelsen Olle Engkvist Byggmästare
- Claes-Göran Östenson
Cancerfonden
- Maria Pernemalm
- Janne Lehtiö
Stiftelsen för Strategisk Forskning
- Maria Pernemalm
- AnnSofi Sandberg
- Yafeng Zhu
- Janne Lehtiö
Horizon 2020 Framework Programme
- Maria Pernemalm
- Janne Lehtiö
Familjen Erling-Perssons Stiftelse
- Janne Lehtiö
Barncancerfonden
- Janne Lehtiö
Stockholms Läns Landsting
- Claes-Göran Östenson
the Swedish Council for Working Life and Social Research
- Claes-Göran Östenson
Swedish Diabetes Foundation
- Claes-Göran Östenson
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: The plasma collections were approved by local ethics boards and all participants signed informed consent. The approval identifiers for the corresponding studies are as follows; Healthy normals Dnr 91:164 for men and Dnr 95:298 for women, mother/child 2014/1622-31/2 and female longitudinal 2008/915-31/4.
Copyright
© 2019, Pernemalm et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 10,997
- views
-
- 977
- downloads
-
- 60
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta
eLife 8:e41608.
https://doi.org/10.7554/eLife.41608
Further reading
-
- Computational and Systems Biology
- Microbiology and Infectious Disease
Timely and effective use of antimicrobial drugs can improve patient outcomes, as well as help safeguard against resistance development. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is currently routinely used in clinical diagnostics for rapid species identification. Mining additional data from said spectra in the form of antimicrobial resistance (AMR) profiles is, therefore, highly promising. Such AMR profiles could serve as a drop-in solution for drastically improving treatment efficiency, effectiveness, and costs. This study endeavors to develop the first machine learning models capable of predicting AMR profiles for the whole repertoire of species and drugs encountered in clinical microbiology. The resulting models can be interpreted as drug recommender systems for infectious diseases. We find that our dual-branch method delivers considerably higher performance compared to previous approaches. In addition, experiments show that the models can be efficiently fine-tuned to data from other clinical laboratories. MALDI-TOF-based AMR recommender systems can, hence, greatly extend the value of MALDI-TOF MS for clinical diagnostics. All code supporting this study is distributed on PyPI and is packaged at https://github.com/gdewael/maldi-nn.
-
- Computational and Systems Biology
- Genetics and Genomics
Enhancers and promoters are classically considered to be bound by a small set of transcription factors (TFs) in a sequence-specific manner. This assumption has come under increasing skepticism as the datasets of ChIP-seq assays of TFs have expanded. In particular, high-occupancy target (HOT) loci attract hundreds of TFs with often no detectable correlation between ChIP-seq peaks and DNA-binding motif presence. Here, we used a set of 1003 TF ChIP-seq datasets (HepG2, K562, H1) to analyze the patterns of ChIP-seq peak co-occurrence in combination with functional genomics datasets. We identified 43,891 HOT loci forming at the promoter (53%) and enhancer (47%) regions. HOT promoters regulate housekeeping genes, whereas HOT enhancers are involved in tissue-specific process regulation. HOT loci form the foundation of human super-enhancers and evolve under strong negative selection, with some of these loci being located in ultraconserved regions. Sequence-based classification analysis of HOT loci suggested that their formation is driven by the sequence features, and the density of mapped ChIP-seq peaks across TF-bound loci correlates with sequence features and the expression level of flanking genes. Based on the affinities to bind to promoters and enhancers we detected five distinct clusters of TFs that form the core of the HOT loci. We report an abundance of HOT loci in the human genome and a commitment of 51% of all TF ChIP-seq binding events to HOT locus formation thus challenging the classical model of enhancer activity and propose a model of HOT locus formation based on the existence of large transcriptional condensates.
